Acetyldigitoxin
CARDIOVASCULAR SYSTEM
Also known as: acylanid, alpha-Acetyldigitoxin, Desglucolanatoside A
Data last refreshed: (DrugCentral release 2024-11-01)
Key facts
Acetyldigitoxin is an ofm drug catalogued in DrugCentral. It was first approved by the FDA in 1975. DrugCentral lists 1 molecular target, including ATP1A1|ATP1B1|ATP1A3|ATP1B2|ATP1A2|ATP1B3|FXYD2|ATP1A4. Recorded indications include Atrial fibrillation and Congestive heart failure.
- Approval status: ofm (first approved 1975 by the FDA).
- Molecular targets: ATP1A1|ATP1B1|ATP1A3|ATP1B2|ATP1A2|ATP1B3|FXYD2|ATP1A4 (1 listed in DrugCentral).
- Indications: Atrial fibrillation and Congestive heart failure.
- ATC code: C01AA01 (Digitalis glycosides).
- Molecular formula: C43H66O14; molecular weight 806.99 g/mol.
Indications & contraindications
Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).
Indications (2)
- Atrial fibrillation
- Congestive heart failure
Mechanism & targets
Molecular targets (1)
| Target | Gene | Action | Activity |
|---|---|---|---|
| Sodium/potassium-transporting ATPase | ATP1A1|ATP1B1|ATP1A3|ATP1B2|ATP1A2|ATP1B3|FXYD2|ATP1A4 | inhibitor | — |
Regulatory approvals (1)
| Date | Agency | Marketed as | Applicant | Orphan |
|---|---|---|---|---|
| 1975-04-24 | FDA | — | NOVARTIS |
ATC classification
| ATC code | Therapeutic hierarchy |
|---|---|
C01AA01 | CARDIOVASCULAR SYSTEM › CARDIAC THERAPY › CARDIAC GLYCOSIDES › Digitalis glycosides |
Chemical structure
Full physicochemical, ADMET and 3D-structure analysis of Acetyldigitoxin is on its molecule page.
| Molecular formula | C43H66O14 |
|---|---|
| Molecular weight | 806.99 g/mol |
| CAS number | 1111-39-3 |
| InChIKey | HPMZBILYSWLILX-UMDUKNJSSA-N |
| PubChem CID | 5284512 |
Frequently asked questions
Answers are generated from the structured data on this page, not written by hand.
What is Acetyldigitoxin used for?
DrugCentral lists the following indications for Acetyldigitoxin: Atrial fibrillation and Congestive heart failure.
How does Acetyldigitoxin work?
Its molecular targets in DrugCentral include ATP1A1|ATP1B1|ATP1A3|ATP1B2|ATP1A2|ATP1B3|FXYD2|ATP1A4 (inhibitor).
When was Acetyldigitoxin first approved?
Acetyldigitoxin was first approved by the FDA in 1975.
What is the chemical formula of Acetyldigitoxin?
Acetyldigitoxin has the molecular formula C43H66O14 and a molecular weight of 806.99 g/mol.
Browse: all drugs starting with A · drug guides by category · protein targets A–Z.
Sources
- DrugCentral drug card 67 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
- ChEMBL CHEMBL3545057 — compound record and bioactivity
- PubChem CID 5284512 — chemical identifiers
- DrugBank DB00511 — drug record
- FDA UNII 0ZV4Q4L2FU — substance identity
- DailyMed: FDA labels for Acetyldigitoxin — current prescribing information (label search)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.